SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

AAREY DRUGS & PHARMACEUTICALS

BSE: 524412 19 Aug 2025
Healthcare
₹ 64.56
Aarey Drugs & Pharmaceuticals Ltd specializes in Pharmaceuticals within the Healthcare sector.

AAREY DRUGS & PHARMACEUTICALS - Share Price & Details

Market Cap
₹184.0
High /Low
75.8 / 31.3
Stock P/E
44.3
Book Value
₹48.8
Dividend Yield
0.0
ROCE
6.38
ROE
₹2.96
Face Value
10.0
PEG Ratio
-2.95
EVEBITDA
₹16.5
Debt
34.9
CMP / FCF
-351.0
Debt to equity
₹0.25
NP Ann
4.02
High price all time
144.0
Piotroski score
₹4.0
Graham Number
40.3
No. Eq. Shares
2.84
Net CF
₹-0.12
Net profit
4.16
Price to book value
1.34
Interest Coverage
₹2.9
Low price all time
9.02
Industry PE
33.8
Reserves
₹110
Free Cash Flow
₹4.45

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
AAREY DRUGS & PHARMACEUTICALS1037.613.711022.080.48184.044.3
Lotus Eye Hospital And Institu137.045.45135.170.26178273.0
CORAL LABORATORIES LTD.306.1628.27281.357.911729.36

Peer Comparison Chart


About AAREY DRUGS & PHARMACEUTICALS

Aarey Drugs & Pharmaceuticals Ltd, with Security Code 524412, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Aarey Drugs & Pharmaceuticals standalone net profit rises 10.48% in the June 2025 quarter

(14 Aug 2025)
Net profit of Aarey Drugs & Pharmaceuticals rose 10.48% to Rs 1.37 crore in the quarter ended June 2025 as against Rs 1.24 crore during the previous quarter...
Read more →

Pasupati Fincap reports standalone net loss of Rs 0.07 crore in the June 2025 quarter

(14 Aug 2025)
Net Loss of Pasupati Fincap reported to Rs 0.07 crore in the quarter ended June 2025 as against net loss of Rs 0.25 crore during the previous quarter ended...
Read more →

Bharat Textiles & Proofing Industries reports standalone net loss of Rs 0.09 crore in the June 2025 quarter

(14 Aug 2025)
Sales decline 36.21% to Rs 1.85 crore.
Read more →

Aarey Drugs & Pharmaceuticals Reports Mixed Financial Results Amid Operational Challenges in August 2025

(13 Aug 2025)
Aarey Drugs & Pharmaceuticals announced its financial results for the quarter ending June 2025, revealing significant changes in key metrics...
Read more →

Pharmaceuticals Limited (AAREYDRUGS) Sees Unusual Trading Volume - Achieve breakthrough gains with expert advice

(04 Aug 2025)
Pharmaceuticals Limited (AAREYDRUGS) Sees Unusual Trading Volume ✌️【Stock Observations】✌️ Make informed investment decisions with our...
Read more →

Pharmaceuticals Limited (AAREYDRUGS) Stock Experiences Sudden Dip - Dynamic investment opportunities

(04 Aug 2025)
Pharmaceuticals Limited (AAREYDRUGS) Stock Experiences Sudden Dip ✌️【Investor Sentiment】✌️ Join our fast-growing community of smart...
Read more →

Company Updates